Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Octreotide Versus Octreotide Plus Interferon-Alpha in Endocrine Gastroenteropancreatic Tumors: A Randomized Trial
2005
Aggressive surgery for metastatic liver neuroendocrine tumors
2003
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
1993 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
The Infectivity ofCryptosporidium parvumin Healthy Volunteers
1995 Standout
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
1999 Standout
Intensity of Infection in AIDS-Associated Cryptosporidiosis
1993
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Sjögren's syndrome
2005 Standout
A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis
2001
Does the mode of delivery predispose women to anal incontinence in the first year postpartum? A comparative systematic review
2008
Short-term and long-term effects of caesarean section on the health of women and children
2018 Standout
Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
2001
Current issues in the diagnosis and treatment of Sjögrenʼs syndrome
1999
The influence of age on colonic epithelial cell proliferation
1988
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
2001
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics
2001
Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe1-Tyr3-octreotide and chromogranin A assay in patients with neuroendocrine tumours
2008
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Cushing's syndrome
2015 Standout
Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: From molecular modeling to in vivo evaluation
2010
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men
2011 Standout
Neuroendocrine tumor targeting: Study of novel gallium‐labeled somatostatin radiopeptides in a rat pancreatic tumor model
2002
Treatment of neuroendocrine tumors
1994
Fiber and Functional Gastrointestinal Disorders
2013
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Variable gastrointestinal and urologic cancers in a lynch syndrome II kindred
1991
Targeted disruption of the neuronal nitric oxide synthase gene
1993 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
2007
Helicobacter pylori Infection and the Development of Gastric Cancer
2001 Standout
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors
2001
68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
2007
DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals
2003
Carcinoid A Comprehensive Review
2003
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
2006
Bile salt-dependent lipase: its pathophysiological implications
2001
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors
2005
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II)
1991
Survival and Clinical Outcome of Patients with Neuroendocrine Tumors of the Gastroenteropancreatic Tract in a German Referral Center
2004
The primary transcriptome of the major human pathogen Helicobacter pylori
2010 StandoutNature
Helicobacter pyloriInfection in Young Patients with Gastric Carcinoma
1996
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Hereditary Colorectal Cancer
2003 Standout
Ulcerative colitis
2016 Standout
DIETARY FIBER AND BODY-WEIGHT REGULATION
2001
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Transarterial Chemoembolization of Advanced Liver Metastases of Neuroendocrine Tumors – A Retrospective Single-Center Analysis
2003
Usefulness of Somatostatin Receptor Scintigraphy in Patients with Occult Ectopic Adrenocorticotropin Syndrome
1999
Cushing's syndrome
2006 Standout
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
2004
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease
1994
Glycaemic response to foods: Impact on satiety and long-term weight regulation
2007
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives
2000
Prospective study of the antitumor efficacy of long‐term octreotide treatment in patients with progressive metastatic gastrinoma
2002
Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors: A study by the Italian Trials in Medical Oncology group
1996
Carcinoid Tumors
1999
Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography
2005
Irritable Bowel Syndrome
2015 Standout
Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor.
1994
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Treating Obesity in Youth: Should Dietary Glycemic Load Be a Consideration?
2001
Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides
2001 Standout
Impaired TGF-β Responses in Peripheral T Cells of Gαi2−/− Mice
2005 StandoutNobel
Identification of two anti-parallel beta-sheet conformations in the solution structure of murine epidermal growth factor by proton magnetic resonance.
1986 StandoutNobel
Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells
1976 StandoutNatureNobel
Conformation and unfolding thermodynamics of epidermal growth factor and derivatives
1976 StandoutNobel
125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.
1976 StandoutNobel
Phase Variation in Helicobacter pylori Lipopolysaccharide
1998
Prognosis of Carcinoid Heart Disease
2005
SEROTONIN IMMUNOREACTIVITY IN CARCINOID TUMOURS DEMONSTRATED BY A MONOCLONAL ANTIBODY
1982 StandoutNobel
Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer
1987
Ectopic ACTH Syndrome and CRH-Mediated Cushing’s Syndrome
1994
Therapeutic Alternatives in Metastatic Neuroendocrine Tumors
1998
Alfred P. Sloan Jr. Award.The epidermal growth factor (EGF)
1983 StandoutNobel
Neuroendocrine Tumor‐Targeted Upconversion Nanoparticle‐Based Micelles for Simultaneous NIR‐Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging
2017
110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET.
2002
Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
2005
Distinguishing right from left colon by the pattern of gene expression.
2003
Cellular localisation of human urogastrone/epidermal growth factor
1978 Nature
Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting
2011
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
2003
Isolation and structure of urogastrone and its relationship to epidermal growth factor
1975 StandoutNature
Enteral nutritional therapy for induction of remission in Crohn's disease
2007
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
2018 Standout
Epidermal Growth Factor
1979 StandoutNobel
One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
2008 Standout
CpG island methylator phenotype in colorectal cancer
1999 Standout
Carcinoid-islet cell tumors of the duodenum
1971
Cesarean delivery for the prevention of anal incontinence
2010
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Infantile hypertrophic pyloric stenosis: A review
1982
Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas
2004
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of M Mignon being referenced
L'OFFICE CURIAL DANS UN CONTEXTE DE PÉNURIE DE PRÊTRES
1968
Endocrine tumors of the pancreas : recent advances in research and management
1995
Long-term efficacy of radionuclide therapy in patients with disseminated neuroendocrine tumors uncontrolled by conventional therapy.
2004
Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).
1997
Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.
1992
Gastric secretion of platelet activating factor and precursors in healthy humans: effect of pentagastrin.
1993
Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison.
1996
Polymerase chain reaction assay for the detection of Helicobacter pylori in gastric biopsy specimens: comparison with culture, rapid urease test, and histopathological tests.
1994
Epithelial cell proliferation in the rectal stump of patients with ileorectal anastomosis for ulcerative colitis.
1983
Long acting somatostatin treatment of paraneoplastic Cushing's syndrome in a case of Zollinger-Ellison syndrome.
1988
The Use of New Somatostatin Analogues, Lanreotide and Octastatin, in Neuroendocrine Gastro-lntestinal Tumours
1996
A diffuse T lymphocytic gastrointestinal mucosal infiltration associated with Sjögren's syndrome resulting in a watery diarrhea syndrome and responsive to immunosuppressive therapy
1998
Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome
1994
Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?
1993
Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison
1996
Somatostatin receptor subtype gene expression in human endocrine gastroentero‐pancreatic tumours
1997
Pouchitis—A poorly understood entity
1995
Natural History of Neuroendocrine Enteropancreatic Tumors
2000
Imaging appearances of metastases from neuroendocrine tumours of the pancreas
2001
Transforming Growth Factor-α and Epidermal Growth Factor Receptor in Colonic Mucosa in Active and Inactive Inflammatory Bowel Disease
2000
Effect of psyllium on gastric emptying, hunger feeling and food intake in normal volunteers: a double blind study
1998
Les gastrinomes dans les néoplasies endocriniennes multiples de type 1. Une étude de cohorte de 127 cas du groupe des tumeurs endocrines (GTE)
2004
Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1
1999
Clinical, Anatomical, and Evolutive Features of Patients with the Zollinger-Ellison Syndrome Combined with Type I Multiple Endocrine Neoplasia
1993
Are sphincter defects the cause of anal incontinence after vaginal delivery?
2000
Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors a prospective phase II study in 24 patients
1993
Refeeding improves muscle performance without normalization of muscle mass and oxygen consumption in anorexia nervosa patients
1997
Standardisation of imaging in neuroendocrine tumours: results of a European delphi process
2001
Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet.
1991
False-positive somatostatin receptor scintigraphy due to an accessory spleen.
1997
[Postpartum sphincter rupture and anal incontinence: prospective study with 259 patients].
2000
[Familial colonic cancer (Lynch's syndrome) and bile duct cancer. Study of 2 cases].
1989
Preoperative Diagnosis and Surgical Management of Neuroendocrine Gastroenteropancreatic Tumors: General Recommendations by a Consensus Workshop*
1998
Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome**
1995
[Influence of rectal preparation by enema on cell proliferation in the normal rectal mucosa in man].
1984
Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
1999
Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.
2002
Intestinal infections in patients with acquired immunodeficiency syndrome
1989
Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
1997
[Intravenous chemotherapy with streptozotocin and 5 fluorouracil for hepatic metastases of Zollinger-Ellison syndrome. A prospective multicenter study in 21 patients].
1991
Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists
1986
Serum gastrin levels in hypertrophic pyloric stenosis of infancy. Response to a gastrin secretion test.
1979
Current approach to the management of tumoral process in patients with gastrinoma
1986
Diagnosis and treatment of Zollinger-Ellison syndrome
1988